Mental Retardation News and Research

RSS

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

16 Mar 2009

Potential pathway for drug intervention

A newly identified molecular pathway that directs stem cells to produce glial cells yields insights into the neurobiology of Down's syndrome and a number of central nervous system disorders characterized by too many glial cells, according to a recent study by researchers at the Salk Institute for Biological Studies.

15 Mar 2009

Prenatal molecular diagnosis for tuberous sclerosis complex

Geneticists from Boston University School of Medicine (BUSM) have reported the world's first series of cases of prenatal diagnosis for women at risk of having a child with tuberous sclerosis complex (TSC).

2 Mar 2009

Iodine in pregnancy, needs, impact and controversy

The American Thyroid Association has recommended that all pregnant and breastfeeding women in the U.S. should take daily supplements containing 150 mcg iodine.

25 Feb 2009

Use of potassium iodide encouraged by BUSM researchers

Researchers from Boston University School of Medicine (BUSM) are strongly encouraging prenatal vitamin manufacturers to use only potassium iodide and not other sources of iodine in their products.

25 Feb 2009

States expand newborn screening for life-threatening disorders

Regardless of where they are born in the United States, nearly all newborns now receive mandated screening for many life-threatening disorders, a remarkable public health advance of the last four years, according to a new report issued today by the March of Dimes.

20 Feb 2009

Lack of specific gene plays role in autism

It is estimated that three to six out of every 1,000 children in the United States have autism - and the number of diagnosed cases is rising.

9 Feb 2009

Missing gene plays role in autism

It is estimated that three to six out of every 1,000 children in the United States have autism - and the number of diagnosed cases is rising.

8 Feb 2009

Discovery of the novel Fragile X granule could lead to new autism treatment

A Brown University research team has discovered something in the brain that could serve as a target for future autism and mental retardation treatments.

5 Feb 2009

Genetic testing may not lead to demand for 'designer babies'

A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age.

27 Jan 2009

Missing DNA the culprit in epilepsy?

An international team of scientists have identified a genetic risk factor for epilepsy which may lead to a better understanding of what causes the seizures and the development of new treatments for the condition.

12 Jan 2009

United States preterm birth rate continues to rise

New government statistics confirm that the decades-long rise in the United States preterm birth rate continues, putting more infants than ever at increased risk of death and disability.

7 Jan 2009

New drug being tested for Fragile X syndrome

A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome (FXS).

6 Jan 2009

Exercise great for children with developmental disabilities

Group exercise programs, treadmill training and horseback riding can be healthy choices for children with developmental disabilities, a new review of studies concludes.

1 Jan 2009

Serious health problems related to late preterm births

More than half a million babies are born preterm in the United States each year, and preterm births are on the rise.

12 Dec 2008

Merck Serono's Kuvan receives European marketing authorization

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the European Commission has granted marketing authorization for Kuvan(R) for the treatment of hyperphenylalaninemia (HPA) in phenylketonuria (PKU) or BH4 deficient patients.

10 Dec 2008

Scientists pinpoint immune-system targets in complex pathogens

Our immune cells have an amazingly intricate recognition system to detect invading pathogens. Often, the intricacies have overwhelmed scientists who want to know exactly what gives an alarm signal to T cells, a class of white blood cells that recognizes invaders.

7 Dec 2008